Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicin

Published:1992-01 Issue:10 Volume:28 Page:1670-1676
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Herait P.,Poutignat N.,Marty M.,Bugat R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference82 articles.

1. Comparative experimental studies on 4′-0-tetrahydropyranyl-adriamycin and adriamycin;Umezawa,1983

2. Report on the Phase II Studies of THP-Adriamycin, Personal data of the Laboratoire Roger Bellon,1989

3. Reporting results of cancer treatment;Miller;Cancer,1981

4. Phase II evaluation of 4′ epidoxorubin in patients with metastatic colorectal carcinoma;Ajani;Cancer Treat Rep,1984

5. Phase II trial of 4′ epidoxorubicin in patients with advanced malignant melanoma;Berman;Cancer Treat Rep,1984

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial;BMJ Open;2024-04

2. Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-Hodgkin's lymphoma by LC–MS/MS method;Journal of Chromatography B;2023-05

3. Echocardiographic Study of Left Ventricular Pressure-Strain Loop in Evaluating Changes in Left Ventricular Myocardial Work in Breast Cancer Patients After Chemotherapy;International Heart Journal;2023-03-31

4. Ring finger protein 10 improves pirarubicin-induced cardiac inflammation by regulating the AP-1/Meox2 signaling pathway;Toxicology and Applied Pharmacology;2023-03

5. Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation;Leukemia Research;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3